A company still losing money with shrinking sales.
Going well
Sales up 39% last year
No debt reported
Watch out for
Sales down 91% in the latest quarter vs a year ago
About 15 months of cash left at its current burn
Losing money, losses are large next to sales
Money moves
Insiders sold $358K in the last 30 days
Institutions cut 0.9% from their holdings in the quarter ending June 2026 (83 bought, 102 sold)
Facts from SEC filings, not a recommendation.
What the price means
Price as of Oct 26
$28.38+0.6% that day
Company value
$2.0B
Share price times all shares
Price vs sales
54.2x
No profit over the last year, so this compares value with sales instead
Cash vs value
9%
Cash as a share of company value
From ZYME's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.
The business over time
Last 12 quarters, from SEC filings
Sales, Jun '26
$4.6M-91% vs a year earlier
Sep '23Tap a barJun '26
Last 12 months: $37.1M, down 70% from the 12 months before. Over 5 years, sales grew about 22% a year.
What the price assumes
Your guesses, our math
Move the sliders to your own view of ZYME. Starting points are the company's recent numbers (it isn't profitable yet, so the margin starts at a 10% guess).
Sales in 5 years$22M
Profit in 5 years$2M
Price these guesses point to$0.36-99% vs $28.38 todayAbout -58% a year, before dividends
Simple math on your guesses, not a forecast or a price target. Real results depend on many things these sliders leave out.
The checklist Warren Buffett-style investors use. Annual numbers for 2025.
1/6Weak
MissReturn on equity 15%+Earns a lot on the money owners have in the business.-26.7%
PassDebt under half of equityNot relying on borrowed money.No debt reported
MissNet margin 10%+Keeps at least 10 cents of profit from each dollar of sales.-76.6%
MissProfitable every yearSteady profits, not one good year.1 of 6 years
MissFree cash flow positiveBrings in more cash than it spends to run and grow.-$34.5M
MissShare count not growingNot diluting owners. Falling means buybacks.+15.6% in 3 years
Revenue
$106.0M
+38.9% vs prior year
5-year growth
+22.2%/yr
revenue, per year
Total debt
None
0.00x equity
Current ratio
5.88x
short-term assets / bills due
From annual reports filed with the SEC. Not in this company's SEC data, so not scored: gross margin 40%+. A checklist is a starting point for research, not a verdict.
Latest quarter
Quarter ended Jun 30, 2026
Reported Aug 6
Revenue
$4.6M
-90.6% YoY
EPS
-$0.62
vs $0.03
Op. margin
-919.0%
-917.6 pts
Free cash flow
-$31.9M
Share count
-5.7%
vs a year ago
Insider rating
Last 90 days
35Selling
1 insider sold $358K (not pre-planned)
50 is neutral. Buying by more insiders, top executives and bigger stakes raises it. Selling lowers it; pre-planned sales count less.
Weekly insider trend
13 weeks agoBoughtSoldThis week
Filing buzz
Last 7 days vs normal
88/ 100
This week
4
Normal week
0.5
vs normal
7.3x
SEC filings of any kind. 50 means a normal week.
Institutional ownership
■Steady-0.9%
Institutions cut 0.9% from their holdings. 83 bought, 102 sold. 4 quarters of net selling in a row.
Shares held by institutions69.6M
Sep '24Jun '26
Safety check
From SEC filings
Share count growthYearly rate, last 3 years
+1.5%
Cash runwayAt last year's cash burn
65 months
Debt to equityLatest balance sheet: debt compared with what owners have
No debt reported
Shares outstandingLatest reported
71M
Why moderate risk
Losing money, losses are large next to sales
Earnings reports
Last 12
Next reportAround Nov 5 (est.)Estimated from the same quarter last year
Results filedAug 6
Results filedMay 7
Results filedMar 2
Results filedJan 12
Results filedNov 6, 2025
Flags and big holders
Offerings 6 months, flags 12 months, holders 90 days
No offerings, red flags or new big holders. Clean record.